Angiotensinogen gene and p16 tumor suppressor gene regulatory update

MYGN received U.S. Patent No. 5,998,145 covering the use of the angiotensinogen (AGT) gene in MYGN's CardiaRisk test to determine predisposition to hypertension. MYGN also received U.S. Patent No. 6,...